DehydraTECH™ is Lexaria's patented drug delivery formulation and processing platform technology which improves the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral delivery. Since 2016, Lexaria has developed and investigated DehydraTECH with a variety of beneficial molecules in oral and topical formats. DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption and has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier, which Lexaria believes to be of particular importance for centrally active compounds. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio and many patents pending worldwide. For more information, please visit www.lexariabioscience.com.
Company Details
- Employees
- 7
- Address
- #100-740 Mccurdy Rd, Kelowna,british Columbia V1x 2p7,canada
- Phone
- (250) 765-6424
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- lexariabioscience.com
- HQ
- Kelowna, British Columbia
Lexaria Bioscience Questions
Lexaria Bioscience's helpline number is (250) 765-6424
Lexaria Bioscience's website is lexariabioscience.com
Lexaria Bioscience's LinkedIn profile is https://ca.linkedin.com/company/lexaria-bioscience
Lexaria Bioscience has
7 employees.
View email and phone details for 7
employees at Lexaria Bioscience.
Lexaria Bioscience's industry is
Biotechnology Research
Lexaria Bioscience's top competitors are
Regenix Biosciences Ltd.,
Neurocrine Biosciences,
Biocom California,
Cellectar Biosciences, Inc.,
Pacira Biosciences, Inc.,
Clarity Pharmaceuticals,
Moleculin Biotech, Inc.,
Xingimaging, Llc,
Crescent Biopharma,
Glycomimetics.
Lexaria Bioscience's categories are Biotechnology Research
